Concepedia

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis1Part of this work was presented in abstract form at the Twenty-Seventh Annual Meeting of the Society for Neuroscience, October 25–30, 1997, New Orleans, LA, USA.1

Frank Padberg, Wolfgang Feneberg, Stephan Schmidt, Markus Schwarz, Dirk Körschenhausen, B. D. Greenberg, Tom Nolde, Norbert Müller, H Trapmann, N. König,

Journal of Neuroimmunology · 1999 · 87 citations · 28 references

DOI

Concepts

References

28

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · Neurology · 1983 · 14.9K citations

, , +14

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology · 1983 · 7.4K citations

, , +12

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations

, , +17

Identification of autoantibodies associated with myelin damage in multiple sclerosis

Claude P. Genain, Barbara Cannella, Stephen L. Hauser et al. · Nature Medicine · 1999 · 890 citations

, , +14

IL-6-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Roles of IL-6 in the Activation and Differentiation of Autoreactive T Cells

Elena B. Samoilova, Jennifer L. Horton, Brendan Hilliard et al. · The Journal of Immunology · 1998 · 442 citations · Full text

, , +17